Provided by Tiger Fintech (Singapore) Pte. Ltd.

SAB Biotherapeutics, Inc.

2.23
+0.350018.62%
Post-market: 2.250.0198+0.89%19:44 EDT
Volume:259.30K
Turnover:555.67K
Market Cap:20.72M
PE:-0.60
High:2.31
Open:1.85
Low:1.85
Close:1.88
Loading ...
Mar 08, 2024

Major Issues Report

Form 8-K - Current report
Feb 23, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 02, 2024

Major Issues Report

Form 8-K - Current report
Jan 26, 2024

Major Issues Report

Form 8-K - Current report
Jan 25, 2024

Major Issues Report

Form 8-K - Current report
Jan 19, 2024

Major Issues Report

Form 8-K - Current report
Jan 03, 2024

Major Issues Report

Form 8-K - Current report
Dec 04, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 29, 2023

Major Issues Report

Form 8-K - Current report
Nov 25, 2023

Correspondence

Form CORRESP - Correspondence
Nov 22, 2023

Major Issues Report

Form 8-K - Current report
Nov 20, 2023

Major Issues Report

Form 8-K - Current report
Nov 14, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]
Nov 13, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 28, 2023

Major Issues Report

Form 8-K - Current report
Oct 16, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 02, 2023

Major Issues Report

Form 8-K - Current report